VectorBuilder

This May, the VectorBuilder team is heading to key conferences across the globe! 🌍 Come meet our team and learn how our research and CDMO solutions are helping accelerate breakthroughs.

Take a break and have lunch with @VectorBuilder :) humangenetics.ucsf.edu/lunch-and-lear…

Tired of the clone wars? VectorBuilder’s got your back. Check out our Vector Design Studio and use our stable cell line engineering service to find the cells you’re looking for. Happy Star Wars Day, and may the force be with you! #starwars

We're headed to Denver, Colorado for #ARVO2026 VectorBuilder will be at Association for Research in Vision and Ophthalmology (@ARVOinfo)'s Annual 2026 Conference. Come visit Booth 8082 to learn about VectorBuilder's latest services and products to support ophthalmology research. Don't miss out on our educational presentation sessions by Croydon Fernandes (Scientific Liaison) and Dr. Ricky Nemeth (Territory Manager).

It's the final day of #CDMOWeek 🧬 The conversation doesn’t stop here, this is just the beginning for what’s next in gene delivery!

Day 4 of #CDMOWeek 🧬 Juggling vector design, optimization & manufacturing? 😵‍💫 VectorBuilder helps you do it all, end to end 🚀 From vector design to GMP, all in one place (no chaos). Talk to the CliniVec™ team today for a free consultation!

@nytimes Interested in avian embryo models? Explore our RCAS vectors for replication-competent gene delivery and stable expression. en.vectorbuilder.com/resources/vect…

For day three of our #CDMOWeek, we’re sharing a recent article from the @nytimes highlighting how our customers at Neion Bio are rethinking biologics manufacturing, developing chicken-based systems that aims to use eggs as platforms for drug production. Instead of traditional cell culture, their approach focuses on engineering chickens to produce therapeutic proteins in egg whites. While still early, this exciting approach could offer a simpler, more scalable, and more affordable way to produce complex biologics. We can't wait to see the next steps! nytimes.com/2026/03/26/sci…

It's Day 2 of #CDMOWeek — Meet our Head of CDMO and the VectorBuilder team at #ISCT2026 in Dublin, Ireland! We're excited to exhibit at the International Society of Cell and Gene Therapy's Annual Conference (@ISCTglobal ) Be sure to stop by Booth 1905 to learn how VectorBuilder is supporting cell and gene therapy development and translational research from our latest array of products and services. Meet the Team 🧬 Alan Griffith - Head of CDMO 🧬 Christina McClure - Associate Sales Director 🧬 Tasnim Hussain - Territory Manager

VectorBuilder will be at two key conferences in Korea this week! 🧬 BioKorea 2026 Conference April 28th ~ 30th, 2026 🧬 Korean Basic Medical Sciences (KBMS) Conference 2026: April 29th ~ 30th, 2026 Meet Sangwoo Bae at the BioKorea 2026 Conference and Kay Hwang at the KBMS 2026 Conference to discover our latest products and services, tailored for your research needs. Looking forward to seeing you there!

It's the first day of our #CDMOWeek 🧬 VectorBuilder is a full-service CDMO with extensive expertise in process and analytical development, and GMP-grade gene therapy vector manufacturing. We support the full spectrum of vector design, production, and QC needs along the entire gene therapy development pipeline. Hear from our head of CDMO operations, Dr. Alan Griffith, on what Vector Builder can do.

Tomorrow is DNA Day 🧬 To celebrate the code of life, we’re giving away something just as essential for the lab… a (base) pair of our new science socks. Follow us and tag your favorite labmate to enter. Share to your story for an extra entry. 3 winners will be announced on May 8!

It’s the last day of #AACR2026 and have you met Austin? With a diverse background in the research pipeline, Dr. Austin Hammer reflects upon his journey and the discussions he has been having with other attendees. Stop by our Booth 4153 for a chat!

Have you bumped into Sam at #AACR2026? We pulled Samuel Wirth, PhD aside to hear more about his research days, advice to give young scientists, and what he is looking forward to at AACR 2026. Stop by our Booth 4153 and be sure give him a quick “hi!”

Play scientific conference bingo with us at American Association for Cancer Research (@AACR) Annual Meeting 2026. See how many we can tick off on our way to the VectorBuilder booth (#4153). 👀 #AACR2026

☀️VectorBuddy and the VectorBuilder team are in sunny San Diego for #AACR2026! We are excited to discuss our newest offerings and services to support your cancer research, so be sure to check out Booth 4153 and connect with: - Dr. Sam Wirth, Territory Manager - Dr. Austin Hammer, Territory Manager - Croydon Fernandes, Scientific Liaison You won't want to miss our newest swag and our raffle, so don't forget to stop by the booth before Wednesday, April 22! (@AACRFoundation)

Are you ready to kick-off #IMMUNOLOGY2026? The VectorBuilder team is excited to join the American Association of Immunologists at their annual IMMUNOLOGY conference in Boston. Stop by Booth 427 and chat with Dr. Jingjing Lou and Dr. Morgan Dwyer for more insight on our latest research offerings and services! 🗓️ April 15-19, 2026 📍Booth 427 - Thomas M. Menio Convention & Exhibition Center Hall A

Will you be at the @ASGCTherapy Annual Meeting? Join us at the Tools and Technology Forum, where Dr. Bruce Lahn will present “From Research to Clinic: A Practical Guide to Optimizing Therapeutic Vector Design.”

Our new preprint introduces MuteFree™ AAV, a high-stability vector system designed to address ITR instability, a common challenge in gene therapy development. The manuscript is now available on bioRxiv: biorxiv.org/content/10.648… ITR mutations, found in ~40% of AAV transfer plasmids, can reduce yield, introduce variability, and impact therapeutic performance. MuteFree™ AAV preserves ITR integrity through optimized plasmid design, enabling consistent, high-fidelity AAV production within standard workflows. By improving stability at the source, it supports more reliable and scalable gene therapy manufacturing.